Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

This study is currently recruiting participants.

Verified November 2012 by National Cancer Institute (NCI)

Sponsor:

Collaborator:

National Cancer Institute (NCI)

Information provided by:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00899990

First received: May 9, 2009

Last updated: November 22, 2012

Last verified: November 2012

History of Changes

Tracking Information

First Received Date ^ICMJE

May 9, 2009

Last Updated Date

November 22, 2012

Start Date ^ICMJE

February 2008

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Banking of biological specimens, including associated demographic and clinical data [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00899990 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

Official Title ^ICMJE

A COG Study for Collecting and Banking Ewing Sarcoma Specimens

Brief Summary

RATIONALE: Collecting and storing samples of tumor tissue, bone marrow, and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing samples of tumor tissue, bone marrow, and blood from patients with Ewing sarcoma.

Detailed Description

OBJECTIVES:

Collect biological specimens, including associated demographic and clinical data, from patients with Ewing sarcoma.
Provide a repository for long-term storage of Ewing sarcoma-related biological materials.
Make collected specimens available to qualified researchers to understand the biology of Ewing sarcoma and correlate these results with demographic and clinical data.

OUTLINE: This is a multicenter study.

Patients undergo collection of tumor specimens, bone marrow, and peripheral blood at diagnosis. Associated demographic and clinical data are collected and archived.

Patients who are not enrolled on a therapeutic clinical trial are followed annually.

PROJECTED ACCRUAL: Not specified.

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Not Provided

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Not Provided

Study Population

Not Provided

Condition ^ICMJE

Sarcoma

Intervention ^ICMJE

Other: biologic sample preservation procedure
Other: medical chart review

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

Not Provided

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

DISEASE CHARACTERISTICS:

Diagnosis of Ewing sarcoma, including peripheral primitive neuroectodermal tumor and Askin tumor
- Newly diagnosed or recurrent disease

PATIENT CHARACTERISTICS:

Not specified

PRIOR CONCURRENT THERAPY:

Not specified

Gender

Both

Ages

up to 21 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Not Provided

Location Countries ^ICMJE

United States, Australia, Canada, New Zealand, Puerto Rico, Switzerland

Administrative Information

NCT Number ^ICMJE

NCT00899990

Other Study ID Numbers ^ICMJE

CDR0000544202, COG-AEWS07B1

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Children's Oncology Group

Collaborators ^ICMJE

National Cancer Institute (NCI)

Investigators ^ICMJE

Study Chair:	Stephen Lessnick, MD, PhD	University of Utah
Study Chair:	Richard Gorlick, MD	Children's Hospital at Montefiore

Information Provided By

National Cancer Institute (NCI)

Verification Date

November 2012

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top